HOME
MARKET
TRADE
PRICING
PLATFORM
HELP
LOG IN
J&J's Actelion Pharmaceuticals Withdraws Regulatory Filings To Extend Indication Of OPSUMIT In CTEPH
-Reuters
Reuters · 11/12/2019 13:34
Related